🇺🇸 FDA
Patent

US 7067633

Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

granted A61KA61K38/00

Quick answer

US patent 7067633 (Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells) held by The Board of Regents of the University of Texas System expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00